Sofie Struyf

The CC chemokine CCL20 and its receptor CCR6.

J. Van Damme, E. Schutyser, S. Struyf, 2003, Cytokine & growth factor reviews.

Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis.

Els Van Coillie, Catherine Uyttenhove, C. Uyttenhove, 2011, Cancer letters.

Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.

G. Opdenakker, J. Van Damme, S. Noppen, 2010, Human pathology.

Diverging binding capacities of natural LD78β isoforms of macrophage inflammatory protein‐1α to the CC chemokine receptors 1, 3 and 5 affect their anti‐HIV‐1 activity and chemotactic potencies for neutrophils and eosinophils

Dominique Schols, Paul Proost, E. De Clercq, 2001, European journal of immunology.

Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy

K. Geboes, J. Damme, S. Struyf, 2006 .

CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue

Paul Rutgeerts, Paul Proost, P. Rutgeerts, 2004, European journal of immunology.

Amino-terminal Truncation of Chemokines by CD26/Dipeptidyl-peptidase IV

Dominique Schols, Paul Proost, E. De Clercq, 1998, The Journal of Biological Chemistry.

The role of CXC chemokines and their receptors in cancer.

J. Van Damme, S. Struyf, Sofie Struyf, 2008, Cancer letters.